_402 2023 UNIVERSAL REGISTRATION DOCUMENT_MICHELIN 5 FINANCIAL PERFORMANCE 2023 consolidated financial statements 17.3 Solesis joint venture Summarized financial data in respect of Solesis are set out in the table below: (in € millions) December 31, 2023 December 31, 2022 Current assets 51 59 of which cash and cash equivalents 7 8 Non-current assets 685 702 of which goodwill 199 225 of which cash allocated to preferred stock 250 251 TOTAL ASSETS 736 761 Current liabilities 133 134 of which current financial liabilities 111 110 Non-current liabilities 253 251 of which non-current financial liabilities 3 - of which preferred stock 250 251 Equity 350 376 TOTAL LIABILITIES AND EQUITY 736 761 (in € millions) 2023 2022 Sales 105 97 Segment EBITDA 34 32 Other operating income and expenses (7) (11) Interest income - - Interest expense (10) (6) Depreciation, amortization and impairment (15) (19) Income tax - (1) NET INCOME/(LOSS) 2 (5) (in € millions) December 31, 2023 December 31, 2022 Net assets (including goodwill) 350 376 CARRYING AMOUNT OF NET INTEREST IN THE JOINT VENTURE 172 184 The equity-accounted share of Solesis’ results included in the Group’s 2023 consolidated income statement represented a profit of €1 million (2022: €2 million loss). 17.4 Financial information about equity-accounted companies The financial statements of equity-accounted companies other than TBC and Solesis, which are not material taken individually, include the following amounts (information presented on a 100% basis): (in € millions) 2023 2022 Assets 3,103 2,758 Liabilities 2,328 1,881 Sales 2,727 2,953 Net income/(loss) (104) (10)
RkJQdWJsaXNoZXIy NzMxNTcx